Nobelpharma America has become the first company to win FDA approval for a topical treatment for facial angiofibroma associated with tuberous sclerosis complex (TSC).
As Incyte Corporation’s recently-minted Opzelura gets off to the races in eczema, the drug has run up against a setback in another dermatology indication.
Gandhinagar (Gujarat) [India], December 6 (ANI/NewsVoir): Arihant School of Pharmacy & Bio-Research Institute, Gandhinagar organized a two-day virtual 15th Indo-US Conference in collaboration with APP Gujarat State Branch, APP American International Branch, APP PharmEdu Healthcare Manage Division on 1st & 2nd December, 2021 in Gandhinagar